Sign in

    Church & Dwight Co Inc (CHD)

    You might also like

    Church & Dwight Co., Inc. develops, manufactures, and markets a wide array of consumer household, personal care, and specialty products. The company is known for its well-recognized brands such as ARM & HAMMER® baking soda products, OXICLEAN® cleaning solutions, VITAFUSION® and L’IL CRITTERS® gummy dietary supplements, BATISTE® dry shampoo, and WATERPIK® water flossers and showerheads . Operating in three segments—Consumer Domestic, Consumer International, and Specialty Products Division (SPD)—the company focuses on delivering quality products across various categories . Seven of their brands, including ARM & HAMMER® and OXICLEAN®, are designated as "power brands" and significantly contribute to their net sales and profits .

    1. Consumer Domestic - Develops and markets a broad range of household and personal care products within the United States, contributing significantly to the company's net sales.
    2. Consumer International - Offers consumer products similar to the domestic segment but focuses on international markets, expanding the company's global reach.
    3. Specialty Products Division (SPD) - Provides specialty products that cater to niche markets, representing a smaller portion of the company's overall sales.
    NamePositionExternal RolesShort Bio

    Matthew T. Farrell

    ExecutiveBoard

    Chairman of the Board of Directors, President and CEO (until April 2025)

    Board Member at Trinseo PLC

    Matthew T. Farrell has been with CHD since 2006, serving in various executive roles, including CFO and COO, before becoming CEO in 2016. He will retire as CEO in April 2025 but remain Chairman for a transition period.

    View Report →

    Carlen Hooker

    Executive

    Executive Vice President, Chief Commercial Officer

    None

    Carlen Hooker joined CHD in 2019 and became Chief Commercial Officer in 2023.

    Patrick D. de Maynadier

    Executive

    Executive Vice President, General Counsel, and Secretary

    None

    Patrick D. de Maynadier has been with CHD since 2011, serving as General Counsel and Secretary. His specific achievements are not detailed in the documents.

    Rene Hemsey

    Executive

    Executive Vice President, Chief Human Resources Officer

    None

    Rene Hemsey has been with CHD since 2001, holding various HR roles. She became Chief Human Resources Officer in 2022.

    Richard A. Dierker

    Executive

    Executive Vice President, CFO, and Head of Business Operations

    None

    Richard A. Dierker joined CHD in 2009 and has held several financial leadership roles. He will transition to CEO in April 2025.

    Arthur B. Winkleblack

    Board

    Director

    Board Member at The Wendy’s Company

    Arthur B. Winkleblack has been a director at CHD since 2008, with extensive experience in finance and strategic planning.

    Bradlen S. Cashaw

    Board

    Director

    COO and Board Member at Agropur

    Bradlen S. Cashaw has been a director at CHD since 2021 and serves on the Audit and Governance Committees. He is also COO of Agropur.

    Bradley C. Irwin

    Board

    Director

    None

    Bradley C. Irwin has been a director at CHD since 2006, contributing to governance and strategy. He is a retired CEO of Welch Foods.

    Janet S. Vergis

    Board

    Director

    Board Member at Teva Pharmaceutical Industries, Dentsply Sirona, and SGS

    Janet S. Vergis has been a director at CHD since 2014, with over 35 years of healthcare leadership experience.

    Laurie J. Yoler

    Board

    Director

    Board Member at Bose Corporation and Saltbox

    Laurie J. Yoler has been a director at CHD since 2018, with a background in technology and venture capital.

    Michael R. Smith

    Board

    Director

    Board Member at MillerKnoll, Inc.

    Michael R. Smith joined CHD as a director in 2024 and serves on the Audit Committee. He is also the CFO of McCormick & Company, retiring in 2025.

    Penry W. Price

    Board

    Director

    VP, Marketing Solutions at LinkedIn

    Penry W. Price has been a director at CHD since 2011, bringing expertise in digital marketing and advertising.

    Ravichandra K. Saligram

    Board

    Lead Director

    Retired CEO of Newell Brands

    Ravichandra K. Saligram has been a director at CHD since 2006 and Lead Director since 2023. He retired as CEO of Newell Brands in 2023.

    Robert K. Shearer

    Board

    Director

    Board Member at YETI Holdings, Inc. and Kontoor Brands, Inc.

    Robert K. Shearer has been a director at CHD since 2008, with a background in corporate finance and auditing.

    Susan G. Saideman

    Board

    Director

    CEO of Portage Bay Limited LLC, Board Member at MYT Netherlands Parent B.V., Prepac Manufacturing Ltd., and FIRST Washington

    Susan G. Saideman has been a director at CHD since 2020, with extensive experience in global vendor management and digital retail.

    1. With the deceleration in growth of key brands like THERABREATH and HERO, despite their strong performance, how do you plan to maintain double-digit growth rates as the law of large numbers takes effect and category growth rates change?

    2. Given the slowdown in underlying category growth and the pressure on organic growth guidance, does your outlook assume further deceleration, and how do you plan to balance price/mix and volumes in this context?

    3. In light of rising commodity costs affecting gross margins, such as increases in pulp, paper, HDPE, and ethylene, what strategies are you implementing to mitigate these pressures and prevent further margin deceleration in the second half?

    4. Considering your disadvantage in the vitamins market due to a less extensive sugar-free portfolio compared to competitors, how are you planning to renovate your product offerings to address shifting consumer preferences towards sugar-free options?

    5. With the departure of key executive Barry, who has been integral to your success, how do you plan to ensure continuity in leadership and strategy, and what is your timeline for filling this critical role?

    Program DetailsProgram 1
    Approval DateOctober 28, 2021
    End Date/DurationNo expiration date
    Total additional amount$1,000.0 million
    Remaining authorization$658.9 million
    DetailsReplaced the 2017 program; aims to manage capital structure and return value to shareholders
    YearAmount Due (in millions)Debt TypeInterest Rate (%)% of Total Debt
    20243.4Various debt due to international banks N/A0.2% = (3.4 / 2,211.6) * 100
    2027425.03.15% Senior Notes 3.15 19.2% = (425.0 / 2,211.6) * 100
    2031400.02.3% Senior Notes 2.3 18.1% = (400.0 / 2,211.6) * 100
    2032500.05.6% Senior Notes 5.6 22.6% = (500.0 / 2,211.6) * 100
    2047400.03.95% Senior Notes 3.95 18.1% = (400.0 / 2,211.6) * 100
    2052500.05.00% Senior Notes 5.00 22.6% = (500.0 / 2,211.6) * 100

    Competitors mentioned in the company's latest 10K filing.

    CompanyDescription

    Competes in the Consumer Domestic and Consumer International segments, with greater financial resources allowing it to outspend on advertising and promotional activities to gain market share.

    Competes in the Consumer Domestic and Consumer International segments, leveraging its resources to compete in product innovation and market share.

    Competes in the Consumer Domestic and Consumer International segments, focusing on personal care and household products.

    S.C. Johnson & Son, Inc.

    Competes in the Consumer Domestic and Consumer International segments, offering a range of household and personal care products.

    Nestle Purina PetCare Company

    Competes in the Consumer Domestic and Consumer International segments, focusing on pet care products.

    Nestle Health Science

    Competes in the Consumer Domestic and Consumer International segments, specializing in health and nutrition products.

    Competes in the Consumer Domestic and Consumer International segments, focusing on health-related consumer products.

    Henkel

    Competes in the Consumer Domestic and Consumer International segments, offering a variety of consumer and industrial products.

    Reckitt Benckiser Group plc

    Competes in the Consumer Domestic and Consumer International segments, focusing on health, hygiene, and home products.

    Competes in the Consumer Domestic and Consumer International segments, leveraging its portfolio of consumer health products.

    Competes in the Consumer Domestic and Consumer International segments, particularly in health and wellness categories.

    Bayer AG

    Competes in the Consumer Domestic and Consumer International segments, focusing on health and nutrition products.

    NBTY, Inc.

    Competes in the Consumer Domestic and Consumer International segments, specializing in dietary supplements.

    Competes in the Consumer Domestic and Consumer International segments, offering health and personal care products.

    Competes in the Consumer Domestic and Consumer International segments, focusing on personal care and household products.

    Competes in the Consumer Domestic and Consumer International segments, particularly in health-related consumer products.

    Pharmavite LLC

    Competes in the Consumer Domestic and Consumer International segments, specializing in dietary supplements.

    Competes in the Consumer Domestic and Consumer International segments, focusing on personal care products.

    Cargill Incorporated

    A key competitor in the Specialty Products Division, particularly in the animal and food production product lines.

    Lallemand Inc.

    A key competitor in the Specialty Products Division, focusing on specialty chemicals and animal nutrition.

    Solvay Chemicals, Inc.

    A key competitor in the Specialty Products Division, operating in specialty chemicals.

    Genesis Alkali

    A key competitor in the Specialty Products Division, specializing in specialty chemicals.

    Natural Soda, Inc.

    A key competitor in the Specialty Products Division, focusing on specialty chemicals.

    NameStart DateEnd DateReason for Change
    Deloitte & Touche LLP1968 PresentCurrent auditor

    Notable M&A activity and strategic investments in the past 3 years.

    CompanyYearDetails

    Graphico, Inc.

    2024

    Completed on June 3, 2024 (with remaining minority shares acquired in July 2024) for a total purchase price of $19.9 million at closing plus $2.0 million for minority interests, financed entirely with cash on hand. The acquisition expands Church & Dwight's APAC presence by adding a Japan-based consumer goods distributor with annual net sales of about $38.0 million and key net asset valuations, including identifiable intangibles and goodwill (which is not U.S. tax-deductible).

    Hero Cosmetics, Inc.

    2022

    Announced on August 31, 2022, and closed on October 13, 2022, the deal was executed using approximately $565 million in cash (with an $8 million holdback) plus $65 million in restricted shares, financed via cash on hand and commercial paper. The acquisition strategically secured a leading brand in acne treatment—Hero Cosmetics, known for its Hero Mighty Patch®—with strong market metrics and continued management retention to drive future growth.